Suppliers / Next Wave India

Next Wave India

India 73 employees Updated 9 July 2026

Next Wave India is a contract manufacturer based in India. It appears in 6 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with TMDA (TZ) and UZPHARM (UZ). Its GMP standing is certified by TMDA (TZ). Customs aggregates show $95K of exports covering 33 molecules to 5 destinations in 2025.

0
active US DMFs
0
valid CEPs
0
registered plants
6
filings across 2 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
TMDA (TZ) 3 1
UZPHARM (UZ) 3 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $49K 3
2025 Not reported $95K 5
2024 Not reported $209K 5
2023 Not reported $62K 3

Export figures are customs aggregates. We do not publish the identity of any buyer.

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Comparing suppliers?

Choose your molecules and target markets. Next Wave India comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts